Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Efforts to Improve Quality of Migraine Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Enhancing HCP Education in Adult Vaccination against Respiratory Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland
    Migraine and Women’s Health
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement, Research Internal Medicine USA
    Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Prostate Cancer: Best Practices for Combining Targeted Therapies in mPC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Real World Experience with Biosimilar Medicines in Oncology
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Improving COVID-19 Outpatient Management (Emerging market countries listed in Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    Quality Improvement in Pediatric Endocrinology fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    COVID-19 Patient Awareness (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Improving Cytogenetic Testing & Treatment Guidance in Adult AML
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Canada
    Acromegaly Research- United States
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Canada
    Best Practices in the Clinical Management of Patients with BRAF-mutant Metastatic Melanoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Innovative Solutions in Atopic Dermatitis and Alopecia Areata Management 2022 I&I IT INNOVA-DERMA
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Italy
    ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy Challenge
    Release Date:
    Partner: ASTRO and Myovant Sciences
    Review Process: Expert Review Panel
    Research Oncology USA
    Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital All